期刊文献+

DF3调控下的白喉毒素A片段对人乳腺癌细胞的特异性杀伤作用 被引量:1

Specific Lethal Effect Of Diphtheria Toxin A Fragment Under Control Of DF3 Promotor for Human Breast Cancer Cells
下载PDF
导出
摘要 目的:研究新构建的含人乳腺癌DF3启动子和白喉毒素A片段的重组表达载体PGL3-DF3-DTA对人乳腺癌细胞的影响。方法:构建重组表达载体PGL3-DF3-DTA,并用其转染DF3阴性和阳性的乳腺癌细胞。采用RT-PCR法检测DTA在乳腺癌细胞中的表达,通过MTT法测定PGL3-DF3-DTA在体外对乳腺癌细胞生长的影响。建立裸鼠动物模型观察PGL3-DF3-DTA在体内对乳腺癌细胞的杀伤效应。结果:重组表达载体PGL3-DF3-DTA在DF3阳性的乳腺癌细胞中高表达,并在体内外均能发挥特异性杀伤作用。结论:重组表达载体PGL3-DF3-DTA能对DF3阳性的乳腺癌细胞产生特异性杀伤作用。 Objective: To study the effects of recombinant expression vector containing human breast cancer DF3 promotor and diphtheria toxin A fragment on human breast cancer cells. Methods: Constructing recombinant expression vector PGL3-DF3-DTA and transfecting it into human breast cancer cells of DF3 positive and negative. By means of RT-PCR to measure the expression of DTA in human breast cancer ceils. MTT color-imetry was used to examine the effect of PGL3-DF3-DTA on growth of human breast cancer cells. By experiment on nude mice to observe the killing effect of PGL3-DF3-DTA on human breast cancer ceils. Results: Recombinant expression vector PGL3-DF3- DTA was highly expressed in human breast cancer cell line of DF3 positive, and it could kill the human breast cancer cells not only in vitro but also in vivo. Conclusion: Recombinant expression vector PGL3-DF3-DTA could produce specific lethal effect on human breast cancer cell line of DF3 positive.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2006年第20期1180-1183,共4页 Chinese Journal of Clinical Oncology
基金 湖北省卫生厅科研基金资助(编号:NX200501)
关键词 DF3 白喉毒素A片段 基因表达 基因治疗 乳腺癌 DF3 ,Diphtheria toxin A gene expression gene therapy human breast cancer
  • 相关文献

参考文献9

二级参考文献64

  • 1Pang S.Targeting and eradicating cancer cells by a prostate-specific vector carrying the diphtheria toxin A gene. Cancer Gene Ther,2000,7(7) :991 - 996.
  • 2Jin N, Chen W, Blazar BR, et al. Gene therapy of routine solid tumors with T cells transduced with a retroviral vascular endothelial growth factor--immunotoxin target gene. Hum Gene Ther,2002,13(4) :497 - 508.
  • 3Liu YY, Gordienko I,Mathias A,et al. Expressioa. of an anti-CD3 single-chain immunotoxin with a truncated diphtheria toxin in a mutant CHO cell line. Protein Expr Purif,2000,19(2) :304 - 311.
  • 4Knechtle SJ. Treatment with immunotoxin. Philos Trans R Soc Lond B Biol Sci,2001,356(1409) :681 - 689.
  • 5Frankel AE, Kreitman R J, Sausvine EA. Targeted toxins. Clin Cancer Res,2000,6:326 - 334.
  • 6Choe S, Bennett M, Fujii G, et al. The crystal structure of diphtheria toxin. Nature, 1992,357 : 216 - 222.
  • 7Kreitman RJ, Pastan I. Immunotoxins for targeted cancer therapy.Adv Drug Deliv Rey, 1998,31:53 - 88.
  • 8Collier RJ. Understanding the mode of action of diphtheria toxin: a perspective on progress during the 20th century. Toxicon, 2001,39: 1793 - 1803.
  • 9Uchida T, Pappenheimer AM Jr, Greany R. Diphtheria toxin and related proteins. I. Isolation and properties of mutant proteins serologically related to diphtheria toxin. J Biol Chem, 1973,248 (11) :3838 - 3844.
  • 10Weetall M, Digan ME, Hugo R, et al. T-cell depletion and graft survival induced by anti-human CD3 immunotoxins in human CD3epsilon transgenic mice. Transplantation, 2002,73 (10) : 1658- 1666.

共引文献20

同被引文献13

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部